Director of Neurochemical Brain Imaging and PET Neurotracer Development
205-934-9814 | Beeper: 7376| Location: WTI 310F
|Robert M. Kessler, M.D. is a Neuroradiologist with over 30 years of experience in both PET and MRI imaging, both at a clinical and research level. He has recently joined the UAB faculty as Professor of Radiology and Director of Neurochemical Brain Imaging and PET Neurotracer Development. Previously, he was the Roentgen Professor of Radiology at the Vanderbilt University School of Medicine where he held a number of positions including Director of Neuroradiology and Positron Tomography. His PET research has included studies of cerebral metabolism, development of dopaminergic and glutamatergic PET radioligands for CNS neurotransmission, schizophrenia, mechanism of action of antipsychotic drugs, reward function, psychostimulant drug abuse, and obesity. Dr. Kessler has received both NIH funding and funding from Pharma for the past 30 years. Dr. Kessler has had considerable clinical experience both in MRI and PET imaging of the brain. He has been an investigator in research fMRI and spectroscopy studies while at Vanderbilt. Dr. Kessler coholds patents both in development of dopamine D2 receptor ligands and in development of MRI pulse sequences. His current interests include the interaction of dopaminergic and glutamatergic neurotransmission in psychiatric and neurological disorders using both PET imaging of neurotransmission, functional MR correlates of changes in neurotransmission – i.e. pharmacological challenges, and 13C spectroscopic studies of glutatmate/GABA cycling.